Publications by authors named "Paul Machui"

Claim this Profile
T
TUB-040, a Homogeneous and Hydrophilic NaPi2b-Targeting ADC with Stably Linked Exatecan, Exhibits Long-lasting Antitumor Activity and a Well-Tolerated Safety Profile.
Annette M Vogl, Saskia Schmitt, Isabelle Mai, Paul Machui, Sarah Herterich

Mol Cancer Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and Evaluation of Phosphonamidate-Linked Exatecan Constructs for Highly Loaded, Stable, and Efficacious Antibody-Drug Conjugates.
Saskia Schmitt, Paul Machui, Isabelle Mai, Sarah Herterich, Swetlana Wunder

Mol Cancer Ther· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Compact hydrophilic electrophiles enable highly efficacious high DAR ADCs with excellent PK profile.
Philipp Ochtrop, Jahaziel Jahzerah, Paul Machui, Isabelle Mai, Dominik Schumacher

Chem Sci· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enantioselective Biocatalytic Reduction of 2 H-1,4-Benzoxazines Using Imine Reductases.
Nadine Zumbrägel, Paul Machui, Jannis Nonnhoff, Harald Gröger

J Org Chem· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis